Table 3. Baseline demographic and clinical characteristics of MCL patients by SCT status.

Factor	SCT (n=13)	Non-SCT (n=39)	Pvalue
Age, years (range)	59(46-71)	71(50-85)	0.001
Sex
Male	12 (92%)	35 (90%)	1.000
Female	1 (8%)	4 (10%)
Time from diagnosis, months (range)	24 (3-87)	32(3-95)	0.106
Bone marrow involvement at study entry, median (range)	6 (46%)	18(46%)	1.000
Duration of last remission, months (range)	14 (0-39)	12(0-49)	0.751
Previous lines of therapy, median (range)	2 (1-3)	2 (1-4)	0.173
Mantle-cell international prognostic index score, median(range)	2 (0-4)	3 (1-7)	0.006

Abbreviations: MCL, mantle-cell lymphoma; SCT, stem cell transplantation.

Data represent median (range) or number(%).